Skip to content

GALECTIN THERAPEUTICS INC.: filings

Every GALECTIN THERAPEUTICS INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q2 202633940001140361-26-032945
10-Q2026-05-15fiscal Q1 202630630001140361-26-021495
10-K2026-03-31fiscal FY 202538760001140361-26-012155
10-Q2025-11-14fiscal Q3 202532920001140361-25-042116
10-Q2025-08-14fiscal Q2 202532920001140361-25-031039
10-Q2025-05-15fiscal Q1 202531640001140361-25-019149
10-K2025-03-31fiscal FY 202437750001140361-25-011169
10-Q2024-11-14fiscal Q3 202432920001140361-24-046726
10-Q2024-08-13fiscal Q2 202432920001140361-24-036937
10-Q2024-05-15fiscal Q1 202432660001140361-24-026105
10-K2024-03-29fiscal FY 202337750001140361-24-016452
10-Q2023-11-13fiscal Q3 202332920001140361-23-052729
10-Q2023-08-14fiscal Q2 202332920001140361-23-039411
10-Q2023-05-15fiscal Q1 202332660001140361-23-024499
10-K2023-03-30fiscal FY 202238760001140361-23-014658
10-Q2022-11-14fiscal Q3 202233940001140361-22-041167
10-Q2022-08-15fiscal Q2 202233940001140361-22-029555
10-Q2022-05-16fiscal Q1 202233680001140361-22-019248
10-K2022-03-31fiscal FY 202138760001140361-22-012058
10-Q2021-11-15fiscal Q3 202133940001140361-21-037756
10-Q2021-08-16fiscal Q2 202127770001193125-21-247072
10-Q2021-05-17fiscal Q1 202127570001193125-21-162797
10-K2021-03-31fiscal FY 202029590001193125-21-101402
10-Q2020-11-09fiscal Q3 202027770001193125-20-288500
10-Q2020-08-10fiscal Q2 202027770001193125-20-214127
10-Q2020-05-11fiscal Q1 202027570001193125-20-138168
10-K2020-03-16fiscal FY 201931620001193125-20-073907
10-Q2019-11-12fiscal Q3 201927770001193125-19-289288
10-Q2019-08-09fiscal Q2 201927770001193125-19-217477
10-Q2019-05-10fiscal Q1 201927570001193125-19-143642
10-K2019-03-06fiscal FY 201833680001193125-19-064705
10-Q2018-11-13fiscal Q3 201826690001193125-18-324862
10-Q2018-08-14fiscal Q2 201826690001193125-18-247867
10-Q2018-05-11fiscal Q1 201824480001193125-18-160824
10-K2018-03-29fiscal FY 201730590001193125-18-100592
10-Q2017-11-07fiscal Q3 201723630001193125-17-335069
10-Q2017-08-14fiscal Q2 201723630001193125-17-256668
10-Q2017-05-15fiscal Q1 201723460001193125-17-169790
10-K2017-03-28fiscal FY 201628590001193125-17-098753
10-Q2016-11-08fiscal Q3 201623640001193125-16-762396
10-Q2016-08-09fiscal Q2 201623640001193125-16-676018
10-Q2016-05-10fiscal Q1 201623470001193125-16-584735
10-K2016-03-15fiscal FY 201529900001193125-16-504330
10-Q2015-11-09fiscal Q3 201523630001193125-15-371080
10-Q2015-08-10fiscal Q2 201523630001193125-15-283901
10-Q2015-05-11fiscal Q1 201525510001193125-15-180669
10-K2015-03-18fiscal FY 201429870001193125-15-096928
10-Q2014-11-10fiscal Q3 201424660001193125-14-404640
10-Q2014-08-07fiscal Q2 201424650001193125-14-300965
10-Q2014-05-13fiscal Q1 201428670001193125-14-197112
10-K2014-03-21fiscal FY 201332760001193125-14-110529
10-Q2013-11-12fiscal Q3 201329860001193125-13-437143
10-Q2013-08-14fiscal Q2 201329830001193125-13-334603
10-Q2013-05-10fiscal Q1 201329670001193125-13-213107
10-K2013-03-29fiscal FY 201232760001193125-13-134503
10-Q2012-11-09fiscal Q3 201226810001193125-12-462829
10-Q2012-08-10fiscal Q2 201226780001193125-12-349558
10-Q2012-05-11fiscal Q1 201226610001193125-12-227792
10-K2012-03-30fiscal FY 201127640001193125-12-143150
10-Q2011-11-10fiscal Q3 201127780001193125-11-306878
10-Q2011-08-12fiscal Q2 201127780001193125-11-220486

Inspect the source

Entity
GALECTIN THERAPEUTICS INC. / CIK 0001133416
Captured
2026-09-20T07:41:17.697Z
SEC response SHA-256
263db289113a9f2a421527d670b3e4f0516c4bb57f4530eb6ae195087a2885de

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001133416.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))